Systematic reviews have shown that functional multidisciplinary rehabilitation improves physical function

and reduces pain in patients with chronic low back pain. However, long-term maintenance of these improvements is inconsistent and the role of exercise in achieving this goal is unclear.

Methods. One hundred five chronic patients with low back pain who had completed a 3-week functional multidisciplinary rehabilitation program were Dibutyryl-cAMP Others inhibitor randomized to either a 3-month exercise program (n = 56) or routine follow-up (n = 49). The exercise program consisted of 24 training sessions during 12 weeks. Patients underwent evaluations of trunk muscle endurance, cardiovascular endurance, lumbar spine mobility (flexion and extension range-of-motion, fingertip-to-floor distance),

pain and perceived functional ability at the beginning and the end of functional multidisciplinary rehabilitation, at the end of the exercise program (3 months) and at 1-year follow-up. Disability was also assessed at the same time points except at the beginning of functional multidisciplinary rehabilitation.

Results. At the end of the functional multidisciplinary rehabilitation, both groups improved significantly in all physical parameters except flexion and extension range-of-motion. At the 3 month and 1 year follow-up, both groups maintained improvements in all parameters except for cardiovascular endurance. Only the exercise program group improved in disability score and selleck products trunk muscle endurance. No differences between groups were found.

Conclusion. A favorable long-term outcome was observed after functional multidisciplinary rehabilitation in both patient groups. Patients who participated in an exercise program obtained some additional benefits. MK-0518 mw The relevance of these benefits to overall health status need to be further investigated.”
“Angiotensin

converting enzyme (ACE) plays a major role in the regulation of blood pressure. The potential antihypertensive activity of Angelica gigas was evaluated in vitro by its ability to inhibit ACE. A methanol extract of A. gigas roots exerted an inhibitory effect against ACE and was fractionated using several organic solvents, including dichloromethane, ethyl acetate, and n-butanol. The n-butanol soluble fraction, which manifested potent ACE inhibitory properties, was further purified via repeated silica gel and RP-18 column chromatography. Three benzopyriansides, such as nodakenin (1), umbelliferone (2), and umbelliferone 6-carboxylic acid (3) were isolated from A. gigas roots. Compounds 1-3 inhibited ACE activity in a dose-dependent manner, with IC50 values of 63.95 +/- 0.16, 190.49 +/- 0.54, and 158.35 +/- 1.53 mu M, respectively. The inhibition kinetics analyzed by Lineweaver-Burk plots revealed that the three compounds showed a mixed-type inhibition. The equilibrium constants for the inhibitor binding (K) of 1, 2, and 3 were estimated to be 1.56×10(-4), 4.70×10(-4), and 2.17×10(-4) M, respectively. We used A.